2014 Gastrointestinal Cancers Symposium - Friday

San Francisco, CA -GI Cancers Symposium 2014: David Goldstein, MD discusses Abstract #178 titled "Updated survival from a randomized phase III trial (MPACT) of nab-paclitaxel plus gemcitabine versus gemcitabine alone for patients (pts) with metastatic adenocarcinoma of the pancreas" during the Oral Abstract Session: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract at the 2014 Gastrointestinal Cancers Symposium here today, Friday January 17, 2014. Over 3,300 physicians, researchers, patient advocates and healthcare professionals from over 50 countries attended the meeting which features the latest research on gastrointestinal cancer treatment and prevention. Photo by © ASCO/Todd Buchanan 2014 Technical Questions: todd@medmeetingimages.com